Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Johnson and Johnson
Mallinckrodt
Express Scripts
AstraZeneca

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Litigation Details for Energy Transportation Group Inc. v. Sonic Innovations Inc. (D. Del. 2005)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Energy Transportation Group Inc. v. Sonic Innovations Inc. (D. Del. 2005)

Docket   Start Trial Date Filed 2005-06-23
Court District Court, D. Delaware Date Terminated 2013-04-26
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand Both Referred To
Parties BERNAFON AG; BERNAFON LLC; ENERGY TRANSPORTATION GROUP INC.; GENNUM CORPORATION; GN RESOUND A/S; GN RESOUND CORPORATION; OTICON A/S; OTICON INC.; PHONAK AG; PHONAK HOLDING AG; PHONAK INC.; PHONAK LLC; RESISTANCE TECHNOLOGY INC.; SONIC INNOVATIONS INC.; STARKEY LABORATORIES INC; UNITRON HEARING INC.; UNITRON HEARING, LTD.; WDH INC.; WIDEX A/S; WIDEX HEARING AID CO INC.; WIDEX USA, INC.; WILLIAM DEMANT HOLDING A/S
Patents 5,529,791; 6,015,713; 6,194,004; 7,078,020; 7,108,866; 9,132,003; 9,302,002
Attorneys Amy Arnott Quinlan; Barry M. Klayman; Brett L. Foster; Brian K. Shelton; Brian M. Buroker; Carl J. Pellegrini; Christopher C. Campbell; David B. Ritchie; David Cushing; David Ellis Moore; David H. Bluestone; Donald A. Degnan; Donald E. Reid; Edmond D. Johnson; Gregory C. Gramenopoulos; J. W. Lytle; Jack B. Blumenfeld; James D. Heisman; James Harry Stone Levine; James R. Sobieraj; James Walter Parrett , Jr.; Jeffrey D. Shewchuk; John M. Romary; Joseph T. Jaros; L. Grant Foster; Leslie A. Polizoti; Linda Elizabeth Beebe; Maria L. Panichelli; Mark A. Miller; Mary B. Graham; Maryellen Noreika; Matthew Allen Kaplan; Maya M. Eckstein; Meredith Martin Addy; N. Richard Powers; Richard L. Horwitz; Richard Swope; Robert E. Camors , Jr.; Robert G. Pluta; Theresa A. Takeuchi; Thomas C. Grimm; Thomas Henry Kovach; Thomas J. Scott; William Mandir
Firms Connolly, Bove, Lodge & Hutz; MetLife, Inc.; Morris, Nichols, Arsht & Tunnell; Napoli Law LLC
Link to Docket External link to docket
Small Molecule Drugs cited in Energy Transportation Group Inc. v. Sonic Innovations Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Energy Transportation Group Inc. v. Sonic Innovations Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Energy Transportation Group Inc. v. Sonic Innovations Inc. (D. Del. 2005)

Date Filed Document No. Description Snippet Link To Document
2007-12-21 484 Exhibit Part 4 of 4 United S'cates Patent NOS. 5,529,791 (the “‘791 patent”) and 7,108,866 (the “‘866 patent”), Which are directed…120 THURSDAY AFI`ERNOON, 11 APRIL 1985 12:`15 Patent Reviewers Luncheon Meeting. Vil'la Capri, M…against Andrx, alleging infringement of the ‘791 patent by dosages of Andrx’s generic diltiazem hydrochloride…against Andrx, alleging infringement of the ‘79l patent by addi*fional dosages of Andrx’s product On October…action against A.ndrx for infringement of the/866 patent On February 22, 2006 and October 17, 2006, the External link to document
2007-12-21 488 Exhibit B (Part Three) 331:21 334:6 336:5,11,12,15 article 5:4,7,10,12 6:15 713 57119 66114,20 6713 71113 73:2,20 ~ , ssa,-(-…in the *350 and the `749 14 patent examiner have considered them? t5 patents, does it'? 15 A. I don…comes out of the 3 A. f don't know. 8 ‘85€} patent in my view. 9 Q. in Peagraph tea you discuss the…of some kind, l in Paragraph 89 you say that the patent 2 and the feedback or feed forward paths provide…because Nyquist 9 wouldn’t have been reviewed by the patent examiner, 10 is the person who first understood External link to document
2007-12-21 489 Exhibit B-Part 3 331:21 334:6 336:5,11,12,15 article 5:4,7,10,12 6:15 713 57119 66114,20 6713 71113 73:2,20 ~ , ssa,-(-…in the *350 and the `749 14 patent examiner have considered them? t5 patents, does it'? 15 A. I don…comes out of the 3 A. f don't know. 8 ‘85€} patent in my view. 9 Q. in Peagraph tea you discuss the…of some kind, l in Paragraph 89 you say that the patent 2 and the feedback or feed forward paths provide…because Nyquist 9 wouldn’t have been reviewed by the patent examiner, 10 is the person who first understood External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Boehringer Ingelheim
Harvard Business School
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.